IRIS Accounts Production v24.3.2.46 12873625 director 1.10.23 30.9.24 30.9.24 false true false false true false iso4217:GBPiso4217:USDiso4217:EURxbrli:sharesxbrli:pureutr:tonnesutr:kWh128736252023-09-30128736252024-09-30128736252023-10-012024-09-30128736252022-09-30128736252022-10-012023-09-30128736252023-09-3012873625ns15:EnglandWales2023-10-012024-09-3012873625ns14:PoundSterling2023-10-012024-09-3012873625ns10:Director12023-10-012024-09-3012873625ns10:PrivateLimitedCompanyLtd2023-10-012024-09-3012873625ns10:SmallEntities2023-10-012024-09-3012873625ns10:AuditExempt-NoAccountantsReport2023-10-012024-09-3012873625ns10:SmallCompaniesRegimeForDirectorsReport2023-10-012024-09-3012873625ns10:SmallCompaniesRegimeForAccounts2023-10-012024-09-3012873625ns10:FullAccounts2023-10-012024-09-3012873625ns10:CompanySecretary12023-10-012024-09-3012873625ns10:RegisteredOffice2023-10-012024-09-3012873625ns5:CurrentFinancialInstruments2024-09-3012873625ns5:CurrentFinancialInstruments2023-09-3012873625ns5:ShareCapital2024-09-3012873625ns5:ShareCapital2023-09-3012873625ns5:RetainedEarningsAccumulatedLosses2024-09-3012873625ns5:RetainedEarningsAccumulatedLosses2023-09-3012873625ns5:FurnitureFittings2023-10-012024-09-3012873625ns5:ComputerEquipment2023-10-012024-09-3012873625ns5:FurnitureFittings2023-09-3012873625ns5:ComputerEquipment2023-09-3012873625ns5:FurnitureFittings2024-09-3012873625ns5:ComputerEquipment2024-09-3012873625ns5:FurnitureFittings2023-09-3012873625ns5:ComputerEquipment2023-09-3012873625ns5:WithinOneYearns5:CurrentFinancialInstruments2024-09-3012873625ns5:WithinOneYearns5:CurrentFinancialInstruments2023-09-3012873625ns5:WithinOneYear2024-09-3012873625ns5:WithinOneYear2023-09-3012873625ns5:BetweenOneFiveYears2024-09-3012873625ns5:BetweenOneFiveYears2023-09-3012873625ns5:AllPeriods2024-09-3012873625ns5:AllPeriods2023-09-30
REGISTERED NUMBER: 12873625 (England and Wales)












Lansdowne Biotechnics Limited

Unaudited Financial Statements

for the Year Ended 30th September 2024






Lansdowne Biotechnics Limited (Registered number: 12873625)






Contents of the Financial Statements
for the Year Ended 30th September 2024




Page

Company Information 1

Statement of Financial Position 2

Notes to the Financial Statements 3


Lansdowne Biotechnics Limited

Company Information
for the Year Ended 30th September 2024







DIRECTOR: D C Lansdowne





SECRETARY: D C Lansdowne





REGISTERED OFFICE: Chi Askorrans
Carluddon Technology Park
Carluddon
St Austell
Cornwall
PL26 8WE





REGISTERED NUMBER: 12873625 (England and Wales)





ACCOUNTANTS: Hodgsons
Chartered Accountants
48 Arwenack Street
Falmouth
Cornwall
TR11 3JH

Lansdowne Biotechnics Limited (Registered number: 12873625)

Statement of Financial Position
30th September 2024

30.9.24 30.9.23
Notes £    £   
FIXED ASSETS
Tangible assets 4 3,412 3,710

CURRENT ASSETS
Debtors 5 16,540 48,090
Cash at bank 44,119 14,497
60,659 62,587
CREDITORS
Amounts falling due within one year 6 (32,614 ) (45,052 )
NET CURRENT ASSETS 28,045 17,535
TOTAL ASSETS LESS CURRENT
LIABILITIES

31,457

21,245

CAPITAL AND RESERVES
Called up share capital 1 1
Retained earnings 31,456 21,244
31,457 21,245

The company is entitled to exemption from audit under Section 477 of the Companies Act 2006 for the year ended 30th September 2024.

The members have not required the company to obtain an audit of its financial statements for the year ended 30th September 2024 in accordance with Section 476 of the Companies Act 2006.

The director acknowledges his responsibilities for:
(a)ensuring that the company keeps accounting records which comply with Sections 386 and 387 of the Companies Act 2006 and
(b)preparing financial statements which give a true and fair view of the state of affairs of the company as at the end of each financial year and of its profit or loss for each financial year in accordance with the requirements of Sections 394 and 395 and which otherwise comply with the requirements of the Companies Act 2006 relating to financial statements, so far as applicable to the company.

The financial statements have been prepared and delivered in accordance with the provisions applicable to companies subject to the small companies regime.

In accordance with Section 444 of the Companies Act 2006, the Income Statement has not been delivered.

The financial statements were approved by the director and authorised for issue on 10th January 2025 and were signed by:





D C Lansdowne - Director


Lansdowne Biotechnics Limited (Registered number: 12873625)

Notes to the Financial Statements
for the Year Ended 30th September 2024

1. STATUTORY INFORMATION

Lansdowne Biotechnics Limited is a private company, limited by shares , registered in England and Wales. The company's registered number and registered office address can be found on the Company Information page.

The presentation currency of the financial statements is the Pound Sterling (£).


2. ACCOUNTING POLICIES

Basis of preparing the financial statements
These financial statements have been prepared in accordance with Financial Reporting Standard 102 "The Financial Reporting Standard applicable in the UK and Republic of Ireland" including the provisions of Section 1A "Small Entities" and the Companies Act 2006. The financial statements have been prepared under the historical cost convention.

Turnover
Turnover is measured at the fair value of the consideration received or receivable, excluding discounts, rebates, value added tax and other sales taxes.

Tangible fixed assets
Depreciation is provided at the following annual rates in order to write off each asset over its estimated useful life.
Fixtures and fittings - 20% on reducing balance
Computer equipment - 20% on reducing balance

Taxation
Taxation for the year comprises current and deferred tax. Tax is recognised in the Income Statement, except to the extent that it relates to items recognised in other comprehensive income or directly in equity.

Current or deferred taxation assets and liabilities are not discounted.

Current tax is recognised at the amount of tax payable using the tax rates and laws that have been enacted or substantively enacted by the statement of financial position date.

Deferred tax
Deferred tax is recognised in respect of all timing differences that have originated but not reversed at the statement of financial position date.

Timing differences arise from the inclusion of income and expenses in tax assessments in periods different from those in which they are recognised in financial statements. Deferred tax is measured using tax rates and laws that have been enacted or substantively enacted by the year end and that are expected to apply to the reversal of the timing difference.

Unrelieved tax losses and other deferred tax assets are recognised only to the extent that it is probable that they will be recovered against the reversal of deferred tax liabilities or other future taxable profits.

Hire purchase and leasing commitments
Rentals paid under operating leases are charged to profit or loss on a straight line basis over the period of the lease.

Pension costs and other post-retirement benefits
The company operates a defined contribution pension scheme. Contributions payable to the company's pension scheme are charged to profit or loss in the period to which they relate.

3. EMPLOYEES AND DIRECTORS

The average number of employees during the year was 5 (2023 - 3 ) .

Lansdowne Biotechnics Limited (Registered number: 12873625)

Notes to the Financial Statements - continued
for the Year Ended 30th September 2024

4. TANGIBLE FIXED ASSETS
Fixtures
and Computer
fittings equipment Totals
£    £    £   
COST
At 1st October 2023 - 4,768 4,768
Additions 275 392 667
Disposals - (291 ) (291 )
At 30th September 2024 275 4,869 5,144
DEPRECIATION
At 1st October 2023 - 1,058 1,058
Charge for year 55 733 788
Eliminated on disposal - (114 ) (114 )
At 30th September 2024 55 1,677 1,732
NET BOOK VALUE
At 30th September 2024 220 3,192 3,412
At 30th September 2023 - 3,710 3,710

5. DEBTORS: AMOUNTS FALLING DUE WITHIN ONE YEAR
30.9.24 30.9.23
£    £   
Trade debtors 7,355 18,295
Other debtors 140 -
Tax 6,753 21,986
Deferred tax asset 1,773 7,490
Prepayments 519 319
16,540 48,090

6. CREDITORS: AMOUNTS FALLING DUE WITHIN ONE YEAR
30.9.24 30.9.23
£    £   
Trade creditors 3,177 -
Social security and other taxes 1,913 -
VAT 7,880 3,971
Other creditors - 557
Directors' current accounts 15,632 15,870
Accruals and deferred income 4,012 24,654
32,614 45,052

Lansdowne Biotechnics Limited (Registered number: 12873625)

Notes to the Financial Statements - continued
for the Year Ended 30th September 2024

7. LEASING AGREEMENTS

Minimum lease payments under non-cancellable operating leases fall due as follows:
30.9.24 30.9.23
£    £   
Within one year 9,500 -
Between one and five years 32,458 -
41,958 -